Conference October 7, 2025 Development of neutralizing antibody (NAb)-evasive and immune cell targeted AAV vectors using sequential selection and machine learning ESGCT Request a Copy
Conference October 7, 2025 In Vivo Directed Evolution of AAV Capsids for Targeting of Skeletal Muscle and Motor Neurons ESGCT Request a Copy
Conference October 7, 2025 Identification of In Vivo-Enriched AAV Variants with Improved Tropism Through Barcoded Capsid Screening ESGCT Request a Copy
Conference October 7, 2025 Localized Gene Therapy: AAV Variants Designed for Smooth Muscle Cell Transduction ESGCT Request a Copy
Conference October 7, 2025 A New Perspective on AAV-mediated In Vivo Direct Reprogramming:Incorporating Exogenous Variables Beyond Cellular Interaction ESGCT Request a Copy
Conference October 7, 2025 Optimization of Large-scale AAV Vector Production Using Fixed-bed bioreactor ESGCT Request a Copy
Conference October 7, 2025 Advancing Directed Evolution: Machine Learning-Guided Optimization of AAV Variants Screening ESGCT Request a Copy
Conference May 13, 2025 From Data to Delivery: AI-Driven Design of Optimized AAV Vectors for Gene Therapy ASGCT Request a Copy
Conference May 7, 2024 Methodologies of High-Throughput Screening Platforms to Enhance the success rates of in vivo directed evolution ASGCT Request a Copy
